Nick Keen

Nicholas Keen is the Chief Scientific Officer at Bicycle Therapeutics, where Nicholas is leading the discovery and development of a new class of medicines. Prior to this, Nicholas held positions at Novartis and AstraZeneca, specializing in oncology drug discovery. Keen's background includes a PhD in Virology and Cancer Biology from the University of Cambridge.